Merkliste 
 1 Ergebnisse 
 
1

Vorapaxar, an oral PAR‐1 receptor antagonist, does not affe..:

Kosoglou, Teddy ; Kumar, Bharath ; Statkevich, Paul...
Clinical Pharmacology in Drug Development.  4 (2014)  1 - p. 56-62 , 2014